• April 3, 2025
TMDX FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages TransMedics Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 15 Deadline in Securities Class Action Commenced by the Firm – TMDX

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc. (NASDAQ: TMDX) between February 28, 2023 and January 10, 2025, both dates inclusive (the “Class Period”), of the important April 15, 2025 lead plaintiff deadline in the securities class action first filed […]

  • April 3, 2025
Free Global Cities: A New Vision for Turning the Migration Crisis into an Opportunity

A groundbreaking new book published today presents a transformative solution to the global migration crisis: self-governed urban prosperity hubs where migrants and refugees can rebuild their lives and contribute to society ZURICH, April 03, 2025 (GLOBE NEWSWIRE) — As conventional approaches fail, Free Global Cities: The Future Leaders in Migration and Public Governance proposes a bold alternative […]

  • April 3, 2025
MRK DEADLINE ALERT: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Merck & Co., Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action – MRK

NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3, 2022 and February 3, 2025, both dates inclusive (the “Class Period”), of the important April 14, 2025 lead plaintiff deadline. SO WHAT: If you purchased Merck […]

  • April 3, 2025
GSK DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages GSK plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – GSK

NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts (“ADRs”) of GSK plc (NYSE: GSK) between February 5, 2020 and August 14, 2022, both dates inclusive (the “Class Period”), of the important April 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased […]